Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ENDOLOGIX INC /DE/ELGX · Entity 146591 | Director | August 12, 2020 | August 14, 2020 |
| Penumbra IncPEN · Entity 3430 | Director | February 13, 2026 | February 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ENDOLOGIX INC /DE/
Report date August 12, 2020 · Filed August 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2020-08-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-08-12 · Sale · Disposed 15,776 · Balance 12,088 Row 2 · 2020-08-12 · Sale · Disposed 12,088 · Balance 0 |
Penumbra Inc
Report date February 13, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 589 |
Reported balance
After 2026-02-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-13 · Grant · Acquired 589 · Balance 589 F1: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Mr. Wilder's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Mr. Wilder's continued service as director through such date. F2: A portion of these shares is subject to vesting. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 4,506 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,506 F3: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Mr. Wilder's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Mr. Wilder's continued service as director through such date.
F2: A portion of these shares is subject to vesting.
F3: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2026 Filed Feb 18, 2026 20:03 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 589 | $0.00 | $0.00 |
DisclosureSEC source: 0001491299-26-000004 · wk-form4_1771463016.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 589 F1 · shares: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Mr. Wilder's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Mr. Wilder's continued service as director through such date. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 19:33 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 186 | $310.72 | $57,793.92 |
DisclosureSEC source: 0001491299-26-000002 · wk-form4_1767746013.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 19:30 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 186 | $253.93 | $47,230.98 |
DisclosureSEC source: 0001491299-25-000005 · wk-form4_1759534248.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 19:44 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 372 | $240.16 | $89,339.52 |
DisclosureSEC source: 0001491299-25-000003 · wk-form4_1755128684.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 372 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: Any changes between direct and indirect holdings through the Thomas and Catharine Wilder Family Trust dated March 31, 2006 are in transactions exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934 as mere changes in form of beneficial ownership. F3 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 20:36 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 360 | $266.93 | $96,094.80 |
DisclosureSEC source: 0001321732-25-000068 · wk-form4_1743813364.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 4,692 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: Any changes between direct and indirect holdings through the Thomas and Catharine Wilder Family Trust dated March 31, 2006 are in transactions exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934 as mere changes in form of beneficial ownership. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 19:34 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 360 | $264.58 | $95,248.80 |
DisclosureSEC source: 0001321732-25-000064 · wk-form4_1743636838.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 4,533 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 19:40 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-25-000031 · wk-form4_1740012006.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,077 F1 · shares: Restricted stock units vest as to 1/4 on each of March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025, subject to Mr. Wilder's continued service as director through such dates. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 19:33 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 665 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-24-000008 · wk-form4_1708561992.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 665 F1 · shares: Restricted stock units vest as to 1/4 on each of March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024, subject to Mr. Wilder's continued service as director through such dates. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 20:11 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 340 | $253.48 | $86,183.20 |
DisclosureSEC source: 0001321732-23-000096 · wk-form4_1691626254.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 340 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:43 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-23-000020 · wf-form4_167711301977688.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894 F1 · shares: Restricted stock units vest as to 1/4 on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023, subject to Mr. Wilder's continued service as director through such dates. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 19:07 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 124 | $223.64 | $27,731.36 |
DisclosureSEC source: 0001321732-23-000004 · wf-form4_167296361971442.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:34 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 124 | $191.20 | $23,708.80 |
DisclosureSEC source: 0001321732-22-000089 · wf-form4_166501643842843.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:28 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 248 | $123.64 | $30,662.72 |
DisclosureSEC source: 0001321732-22-000065 · wf-form4_165715367944101.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 20:55 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-22-000021 · wf-form4_164566769176628.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 710 F1 · shares: Restricted stock units vest as to 1/4 on each of March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, subject to Mr. Wilder's continued service as director through such dates. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 19:34 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 80 | $283.99 | $22,719.20 |
DisclosureSEC source: 0001321732-22-000002 · wf-form4_164142927287943.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:17 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 80 | $267.06 | $21,364.80 |
DisclosureSEC source: 0001321732-21-000089 · wf-form4_163347943295347.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 19:25 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 161 | $275.09 | $44,289.49 |
DisclosureSEC source: 0001321732-21-000052 · wf-form4_162630513357714.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 20:55 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-21-000025 · wf-form4_161413173853938.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535 F1 · shares: Restricted stock units vest as to 1/4 on each of March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021, subject to Mr. Wilder's continued service as director through such dates. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 19:48 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 115 | $174.32 | $20,046.80 |
DisclosureSEC source: 0001321732-21-000006 · wf-form4_160998047597927.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:48 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 115 | $196.06 | $22,546.90 |
DisclosureSEC source: 0001321732-20-000133 · wf-form4_160194530574098.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 18:49 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 12,088 | $0.08 | $1,009.35 |
DisclosureSEC source: 0001013606-20-000168 · wf-form4_159744531907211.xml · nonDerivative · entry 2 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 18:49 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 15,776 | $0.08 | $1,262.08 |
DisclosureSEC source: 0001013606-20-000168 · wf-form4_159744531907211.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,088 Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 20:48 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 230 | $192.47 | $44,268.10 |
DisclosureSEC source: 0001321732-20-000100 · wf-form4_159486046699026.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 20:35 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 756 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-20-000031 · wf-form4_158164412485127.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756 F1 · shares: Restricted stock units vest as to 1/4 on each of March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020, subject to Mr. Wilder's continued service as director through such dates. F2 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:36 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 118 | $164.16 | $19,370.88 |
DisclosureSEC source: 0001321732-20-000007 · wf-form4_157810180019331.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:14 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 118 | $134.93 | $15,921.74 |
DisclosureSEC source: 0001321732-19-000119 · wf-form4_157014802656795.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. F3 · balance_after: Any changes between direct and indirect holdings through the Thomas and Catherine Wilder Family Trust are in transactions exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934 as mere changes in form of beneficial ownership. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 16:29 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantOption to Purchase · Derivative | 417 | Not disclosed Strike: $4.71 | Not disclosed |
DisclosureSEC source: 0001013606-19-000168 · wf-form4_156996177647057.xml · derivative · entry 2 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417 Underlying: Common Stock · 417 shares Expires 2026-09-10 F3 · shares: The options vest in three equal annual installments over a three-year period commencing on September 10, 2019. F2 · price: The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, an option for 1,250 shares of common stock granted to the reporting person on May 20, 2010. In exchange, the reporting person received a new stock option, for 417 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 16:29 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | Disposition to issuerOption to Purchase · Derivative | 1,250 | Not disclosed Strike: $43.60 | Not disclosed |
DisclosureSEC source: 0001013606-19-000168 · wf-form4_156996177647057.xml · derivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires 2020-05-20 F1 · shares: Options vested equally over four years. F2 · price: The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, an option for 1,250 shares of common stock granted to the reporting person on May 20, 2010. In exchange, the reporting person received a new stock option, for 417 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019. Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 20:22 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 1,369 | $6.61 | $9,049.09 |
DisclosureSEC source: 0001013606-19-000155 · wf-form4_156591496053505.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,864 Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 17:16 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantOption to Purchase · Derivative | 9,023 | $6.67 Strike: $6.67 | $60,183.41 |
DisclosureSEC source: 0001013606-19-000135 · wf-form4_156512618668405.xml · derivative · entry 2 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,023 Underlying: Common Stock · 9,023 shares Expires 2029-08-05 F2 · shares: 100% of the option award shall vest on August 5, 2020. Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 17:16 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantCommon Stock | 13,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001013606-19-000135 · wf-form4_156512618668405.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,233 F1 · shares: 100% of the time-based restricted stock unit award shall vest on August 5, 2020 and shall settle in shares of common stock. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 19:14 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 237 | $169.92 | $40,271.04 |
DisclosureSEC source: 0001321732-19-000082 · wf-form4_156340526281218.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,733 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| May 07, 2019 Filed May 9, 2019 19:40 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 1,455 | $6.34 | $9,223.68 |
DisclosureSEC source: 0001013606-19-000092 · wf-form4_155744524454068.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,739 Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 18:31 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 949 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-19-000023 · wf-form4_155001425245289.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,970 F1 · shares: Restricted stock units vest as to 1/4 on each of March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, subject to Mr. Wilder's continued service as director through such dates. F2 · balance_after: A portion of these shares is subject to vesting. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:47 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 152 | $120.59 | $18,329.68 |
DisclosureSEC source: 0001321732-19-000004 · wf-form4_154664566201395.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,021 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| December 30, 2018 Filed Jan 2, 2019 20:00 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantCommon Stock | 120,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001013606-19-000014 · wf-form4_154647718511891.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,947 F1 · kind: 100% of the time-based restricted stock unit award shall vest on December 30, 2019 and shall settle in shares of common stock. Read SEC document |
| October 02, 2018 Filed Oct 4, 2018 21:03 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 151 | $146.96 | $22,190.96 |
DisclosureSEC source: 0001321732-18-000130 · wf-form4_153870137328544.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,173 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 18:59 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 304 | $138.50 | $42,104.00 |
DisclosureSEC source: 0001321732-18-000088 · wf-form4_153152272593773.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,324 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 19:43 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-18-000034 · wf-form4_151926016929298.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,628 F1 · shares: Restricted stock units vest as to 1/4 on each of March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, subject to Mr. Wilder's continued service as a director through such dates. F2 · balance_after: A portion of these shares is subject to vesting. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:40 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 200 | $92.05 | $18,410.00 |
DisclosureSEC source: 0001321732-18-000008 · wf-form4_151511638217921.xml · nonDerivative · entry 2 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,413 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:40 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 145 | $89.90 | $13,035.50 |
DisclosureSEC source: 0001321732-18-000008 · wf-form4_151511638217921.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,613 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $89.90 to $89.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 16:42 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 345 | $90.20 | $31,119.00 |
DisclosureSEC source: 0001321732-17-000159 · wf-form4_150714975909703.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,758 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| July 18, 2017 Filed Jul 20, 2017 20:47 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 345 | $86.10 | $29,704.50 |
DisclosureSEC source: 0001321732-17-000131 · wf-form4_150059800603846.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,103 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · balance_after: A portion of these shares is subject to vesting. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 12:24 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantCommon Stock | 22,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001013606-17-000084 · wf-form4_149642063516270.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,060 Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 19:31 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 1,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-17-000095 · wf-form4_149264466898648.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,448 F1 · shares: Restricted stock units vest as to 1/4 on each of April 17, 2017, June 30, 2017, September 30, 2017 and December 31, 2017, subject to Mr. Wilder's continued service as a director through such dates. F2 · balance_after: A portion of these shares is subject to vesting. F3 · ownership.nature: Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 19:32 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-17-000006 · wf-form4_148435395909348.xml · nonDerivative · entry 1 Wilder Thomas · CIK 0001491299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · security: One quarter of the restricted stock units vest on each of March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.